Delivery Order SPE2DB22D1017-SPE2DB24FF5FD
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,007.76 firm fixed price delivery order is for hydromorphone hydrochloride extended-release 8 mg tablets, with a completion date of February 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical valued at $2,184.76. The award is for the supply of 4,564,222,202 units of Hydromorphone HCL ER 8 mg tablets in 100-count bottles. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA, which...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of 12mg hydromorphone HCL extended-release tablets. The $4,275.66 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, which provides logistics and acquisition services to the U.S. Armed Forces and other government agencies. Amerisourcebergen holds a larger, single-award Indefinite Delivery Contract (IDC) with DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of hydromorphone hydrochloride extended-release tablets, 32 mg, a pain management medication. The contract is a Firm Fixed Price Delivery Order, with a ceiling value of $2,692.00 and a period of performance through November 18, 2024. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, with a ceiling value of $1,741.00, is for the delivery of hydromorphone 1 mg/ml in carpules. This is a firm fixed price delivery order contract with a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the...
- This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $4,711.56 firm-fixed-price delivery order contract is for the supply of 100 count bottles of 8 mg Hydromorphone HCL extended-release tablets. The contract has an ultimate completion date of August 30, 2024 and was awarded on August 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,415.66 Firm Fixed Price delivery order is for the pharmaceutical product hydromorphone hydrochloride extended-release 8 mg tablets, with an ultimate completion date of December 7, 2021. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA...
- This federal contract award, with an ID of SPE2DX22D0010|SPE2D824FAG10, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,623.87 firm fixed-price delivery order is for the supply of 4562388514 - Hydromorphone HCL ER Tabs 32mg, with a completion date of October 5, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $12,546.11 to AmerisourceBergen Drug Corp for the supply of Hydromorphone HCL ER Tablets 12mg, a controlled pain management pharmaceutical. This non-set-aside, competitively awarded contract employs firm fixed pricing and will be completed by October 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,737.60, is a Delivery Order for the supply of 4567387836 ! HYDROMORPHONE 500 MG/50 ML VL 50ML. The contract has an ultimate completion date of February 27, 2025 and is a Firm Fixed Price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF5FDDelivery Order
This federal contract award, with the ID SPE2DB22D1017|SPE2DB24FF5FD, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $2,520.67, is a firm fixed price delivery order for the supply of 4,564,146,984 hydromorphone hydrochloride extended-release 16 mg tablets, with a performance period through April 3, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide these pharmaceutical products from its corporate office located in Conshohocken, Pennsylvania. This award is not associated with any set-aside designations. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 4/2/24 |